Loading…
ABL is a contract development and manufacturing organization (CDMO) specializing in advancing candidate vaccines and therapeutics from preclinical through clinical development. The company focuses on producing and testing oncolytic viruses, gene therapies, immunotherapies, and viral and recombinant protein vaccines.
AI named ABL in December 2025.